UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Quelles nouvelles stratégies dans le traitement du cancer colorectal métastatique avec les biothérapies ?

La revue de medecine interne, 2009-05, Vol.30 (5), p.411-415

2009

Volltextzugriff (PDF)

Choriocarcinome avec atteinte pulmonaire : stratégie diagnostique et thérapeutique

Revue des maladies respiratoires, 2009-09, Vol.26 (7), p.769-772

2009

Volltextzugriff (PDF)

260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A216-A217

2021

Volltextzugriff (PDF)

Facteurs associés à l’efficacité et la tolérance de l’immunothérapie chez la personne âgée ≥ 70 ans

La revue de medecine interne, 2023-06, Vol.44, p.A137-A137

2023

Volltextzugriff (PDF)

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of oncology, 2009-06, Vol.20 (6), p.1042-1047

2009

Volltextzugriff (PDF)

Qualité de vie à long terme et fonction sexuelle des personnes âgées atteintes d’un cancer de l’endomètre ou de l’ovaire

Revue d'épidémiologie et de santé publique, 2019-05, Vol.67, p.S149-S150

2019

Volltextzugriff (PDF)

What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?

La revue de medecine interne, 2009-05, Vol.30 (5), p.411

2009

Volltextzugriff (PDF)

Impact of age on treatment efficacy and safety in metastatic colorectal cancer: A subgroup analysis from the GERCOR Dream phase III study

Journal of geriatric oncology, 2012-10, Vol.3, p.S46-S46

2012

Volltextzugriff (PDF)

The FROG observatory on the tolerance of chemotherapy in the elderly in real life

Journal of geriatric oncology, 2013-10, Vol.4, p.S48-S49

2013

Volltextzugriff (PDF)

What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?

La revue de medecine interne, 2009-05, Vol.30 (5), p.411-415

2009

Volltextzugriff (PDF)

First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study

Bulletin du cancer, 2009-05, Vol.96 (5), p.E18

2009

Volltextzugriff (PDF)

Choriocarcinoma with pulmonary metastasis: diagnosis and treatment

Revue des maladies respiratoires, 2009-09, Vol.26 (7), p.769-772

2009

Volltextzugriff (PDF)

Perforation de la cloison nasale et bevacizumab

La revue de medecine interne, 2011-04, Vol.32 (4), p.e43-e45

2011

Volltextzugriff (PDF)

54P Phase I dose-escalation study of trifluridine/tipiracil plus XB2001 and bevacizumab in chemorefractory advanced colorectal cancer: The TASKIN study

Annals of oncology, 2024-06, Vol.35, p.S26-S26

2024

Volltextzugriff (PDF)

LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial

Annals of oncology, 2023-10, Vol.34, p.S1283-S1284

2023

Volltextzugriff (PDF)

Perceived burden and quality of life of the primary caregiver of patients aged 70 and over with cancer, 5 years after initial treatment

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S71

2021

Volltextzugriff (PDF)

Cervical cancer in older women, does age matter?

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S8

2021

Volltextzugriff (PDF)

SIOG2021-0023 - Cervical cancer in older women, does age matter?

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S8-S8

2021

Volltextzugriff (PDF)

SIOG2021-0047 - Perceived burden and quality of life of the primary caregiver of patients aged 70 and over with cancer, 5 years after initial treatment

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S71-S71

2021

Volltextzugriff (PDF)

808MO Paclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study

Annals of oncology, 2020-09, Vol.31, p.S611-S612

2020

Volltextzugriff (PDF)

823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study

Annals of oncology, 2020-09, Vol.31, p.S621-S622

2020

Volltextzugriff (PDF)

43P Single-arm phase II of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients

Annals of oncology, 2024-06, Vol.35, p.S21-S22

2024

Volltextzugriff (PDF)

Metastatic cancer whole-exome sequencing in daily practice

Annals of oncology, 2019-10, Vol.30, p.v765

2019

Volltextzugriff (PDF)

1884P - Metastatic cancer whole-exome sequencing in daily practice

Annals of oncology, 2019-10, Vol.30, p.v765-v765

2019

Volltextzugriff (PDF)

Predictive Value of Circulating Endothelial Cell (CEC) Levels in Metastatic or Locally Advanced Neuroendocrine Digestive Tumor Patients Treated With Chemotherapy and Bevacizumab

Annals of oncology, 2012-09, Vol.23, p.ix85

2012

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(38)

Sprache

Englisch
(29)
Französisch
(10)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Quelles nouvelles stratégies dans le traitement du cancer colorectal métastatique avec les biothérapies ?

Choriocarcinome avec atteinte pulmonaire : stratégie diagnostique et thérapeutique

260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)

Facteurs associés à l’efficacité et la tolérance de l’immunothérapie chez la personne âgée ≥ 70 ans

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Qualité de vie à long terme et fonction sexuelle des personnes âgées atteintes d’un cancer de l’endomètre ou de l’ovaire

What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?

Impact of age on treatment efficacy and safety in metastatic colorectal cancer: A subgroup analysis from the GERCOR Dream phase III study

The FROG observatory on the tolerance of chemotherapy in the elderly in real life

What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?

First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study

Choriocarcinoma with pulmonary metastasis: diagnosis and treatment

Perforation de la cloison nasale et bevacizumab

54P Phase I dose-escalation study of trifluridine/tipiracil plus XB2001 and bevacizumab in chemorefractory advanced colorectal cancer: The TASKIN study

LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial

Perceived burden and quality of life of the primary caregiver of patients aged 70 and over with cancer, 5 years after initial treatment

Cervical cancer in older women, does age matter?

SIOG2021-0023 - Cervical cancer in older women, does age matter?

SIOG2021-0047 - Perceived burden and quality of life of the primary caregiver of patients aged 70 and over with cancer, 5 years after initial treatment

808MO Paclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study

823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study

43P Single-arm phase II of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients

Metastatic cancer whole-exome sequencing in daily practice

1884P - Metastatic cancer whole-exome sequencing in daily practice

Predictive Value of Circulating Endothelial Cell (CEC) Levels in Metastatic or Locally Advanced Neuroendocrine Digestive Tumor Patients Treated With Chemotherapy and Bevacizumab

Suchergebnisse filtern